Search Within

Neuroradiology Service

  1. "Alan Ho"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (21)
  3. Editorial (1)
Groups
  1. Department of Medicine (44)
  2. Head and Neck Service (44)
  3. Radiology, Department of (44)
  4. Solid Tumor Oncology Division (44)
  5. Biostatistics Service (21)
  6. Epidemiology and Biostatistics (21)

More Groups

People
  1. Alan Ho (44)
  2. David Pfister (40)
  3. Eric Sherman (40)
  4. Sofia Haque (39)
  5. Lara Dunn (24)
  6. Nora Katabi (19)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Cancer (3)
  3. Annals of Oncology (2)
  4. European Journal of Nuclear Medicine and Molecular Imaging (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Cancer Chemotherapy and Pharmacology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. Oxford University Press (4)
  3. Springer (4)
  4. Wiley Blackwell (3)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons (1)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • A pilot study of trametinib in combination with paclitaxel in the treatment of anaplastic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Michel, L. S.; Kriplani, A.; Dunn, L.; Haque, S.; Bang, D.; Stein, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schòˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save